| Literature DB >> 34617427 |
Alexandre Noboru Murakami1, Ulisses Alexandre Croti2, Francisco Candido Monteiro Cajueiro3, Grace Arteaga4, Roxann Barnes Pike4, Airton Camacho Moscardini2, Carlos Henrique De Marchi2, Mariana Ribeiro Rodero Cardoso2, Fernando Cesar Gimenes Barbosa Santos2, Bruna Cury Borim2.
Abstract
INTRODUCTION: End-to-end anastomosis and extended end-to-end anastomosis are typically used as surgical approaches to coarctation of the aorta (CoAo) with access at the subclavian artery or an interposition graft. The objective of this study is to analyze the impact of surgical and anatomical characteristics and techniques on early outcomes after surgical treatment of CoAo without cardiopulmonary bypass through left thoracotomy.Entities:
Keywords: Anastomosis, Surgical; Aorta; Aortic Coarctation; Heart Defects; Morbidity; Thoracotomy
Mesh:
Year: 2021 PMID: 34617427 PMCID: PMC8522329 DOI: 10.21470/1678-9741-2020-0554
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Preoperative data of patients who underwent surgical treatment for coarctation of the aorta.
| Preoperative data | Group A (n=34) | Group B (n=24) | Group C (n=14) | Total (n=72) |
|---|---|---|---|---|
| Male | 19 (55.9%) | 13 (54.2%) | 9 (64.3%) | 41 (56.9%) |
| Prematurity | 3 (8.8%) | 4 (16.7%) | 0 | 7 (9.7%) |
| Weight (mean±SD) [median] | (3.2 ± 0.5) [3.3] | (4.7 ± 2) [4.5] | (23.8 ± 14.8) [18.2] | (7.7 ± 10.2) [3.7] |
| Height (mean±SD) [median] | (48.6 ± 3.6) [49] | (57.2 ± 10.7) [55.5] | (114 ± 28.9) [108.5] | (64.2 ± 28.6) [51] |
| Noncardiac anomalies | 3 (8.8%) | 3 (12.5%) | 0 | 6 (8.3%) |
| Chromosomal abnormalities | 7 (20.5%) | 4 (16.7%) | 1 (7.1%) | 12 (16.7%) |
SD=standard deviation
Group A=≤ 30 days; group B=31 days to 1 year; group C= >1 year to 18 years
Main preoperative diagnosis of cardiac lesions associated to coarctation of the aorta.
| Associated diagnosis | Group A | Group B | Group C | Total |
|---|---|---|---|---|
| Aortic arch hypoplasia | 18 (34%) | 5 (18.5%) | 5 (45%) | 28 (30.8%) |
| Ventricular septal defect | 9 (17%) | 2 (7.4%) | 1 (9%) | 12 (13.2%) |
| Shone's syndrome | 5 (9.4%) | 4 (14.8%) | 1 (9%) | 10 (11%) |
| Atrial septal defect | 7 (13.2%) | 3 (11.1%) | 0 | 10 (11%) |
| Bicuspid aortic valve | 2 (3.8%) | 2 (7.4%) | 1 (9%) | 5 (5.5%) |
| Ebstein's anomaly | 1 (1.9%) | 1 (3.7%) | 0 | 2 (2.2%) |
| Subvalvar aortic stenosis | 0 | 0 | 1 (9%) | 1 (1.1%) |
| Corrected transposition of the great arteries | 1 (1.9%) | 0 | 0 | 1 (1.1%) |
| Partial atrioventricular septal defect | 0 | 1 (3.7%) | 0 | 1 (1.1%) |
| Total atrioventricular septal defect | 1 (1.9%) | 0 | 0 | 1 (1.1%) |
| Unbalanced atrioventricular septal defect | 1 (1.9%) | 0 | 0 | 1 (1.1%) |
| Aortic valve annulus hypoplasia | 1 (1.9%) | 0 | 0 | 1 (1.1%) |
| Pulmonary valvar stenosis | 1 (1.9%) | 0 | 0 | 1 (1.1%) |
| Coronary-cavitary fistula | 1 (1.9%) | 0 | 0 | 1 (1.1%) |
| Parachute mitral valve | 0 | 1 (3.7%) | 0 | 1 (1.1%) |
| Mitral stenosis | 0 | 1 (3.7%) | 0 | 1 (1.1%) |
| Aberrant right subclavian | 1 (1.9%) | 0 | 0 | 1 (1.1%) |
| Total | 53 (100%) | 27 (100%) | 11 (100%) | 91 (100%) |
Persistence of ductus arteriosus was not considered an associated disease, regardless of whether it was patent or occluded at the time of surgery.
Location and type of coarctation of the aorta during operation.
| Group | Location | Type | |||
|---|---|---|---|---|---|
| Preductal | Ductal | Postductal | Discrete | Long-segment | |
| A (n=34) | 25 (73.5%) | 6 (17.6%) | 3 (8.8%) | 13 (38.2%) | 21 (61.8%) |
| B (n=24) | 5 (20.8%) | 10 (41.7%) | 9 (37.5%) | 14 (58.3%) | 10 (41.7%) |
| C (n=14) | 1 (7.1%) | 3 (21.4%) | 10 (71.4%) | 4 (28.6%) | 10 (71.4%) |
Surgical techniques for coarctation of the aorta repair.
| Procedures | Group A (n=34) | Group B (n=24) | Group C (n=14) | Total |
|---|---|---|---|---|
| Extended end-to-end anastomosis | 31 (91.2%) | 15 (62.5%) | 3 (21.4%) | 49 (68%) |
| End-to-end anastomosis | 2 (5.9%) | 9 (37.5%) | 7 (50%) | 18 (25%) |
| Graft interposition of PTFE tube | 0 | 0 | 2 (14.3%) | 2 (2.8%) |
| End-to-end anastomosis using the subclavian
artery | 0 | 0 | 2 (14.3%) | 2 (2.8%) |
| End-to-end anastomosis using the subclavian
artery | 1 (2.9%) | 0 | 0 | 1 (1.4%) |
| Total | 34 (100%) | 24 (100%) | 14 (100%) | 72 (100%) |
n=number of patients; PTFE=polytetrafluoroethylene
Mean aortic clamping time for coarctation of the aorta repair.
| Group A (n=34) | 17 minutes |
| Group B (n=24) | 14 minutes |
| Group C (n=14) | 18 minutes |
| Total (n=72) | 16 minutes |
n=number of patients
Fig. 1Median pre and postoperative aortic arch gradients (in mmHg) for each group.
Postoperative and immediate mortality data post coarctation of the aorta repair.
| Postoperative data | Group A (n=34) | Group B (n=24) | Group C (n=14) | Total (n=72) |
|---|---|---|---|---|
| MV time, hours (mean±SD) [median] | (140.1±256.1) [55.1] | (66.2±120.3) [21.1] | (12.5±30.5) [3.7] | (89.2±192.5) [26.1] |
| Bacterial sepsis | 7 (20.6%) | 4 (16.7%) | 0 | 11 (15.3%) |
| Surgical site infection | 4 (11.8%) | 1 (4.2%) | 1 (7.1%) | 6 (8.3%) |
| Other infections | 2 (5.9%) | 5 (20.8%) | 1 (7.1%) | 8 (11.1%) |
| ICU time, hours (mean±SD) [median] | (330.3±341.4) [194.1] | (339.9±284.8) [156.8] | (142.5±129.6) [88.4] | (261.8±296.3) [167.1] |
| 30-day mortality | 0 | 1 (4.2%) | 0 | 1 (1.4%) |
ICU=intensive care unit; MV=mechanical ventilation; SD=standard deviation
Comparative analysis of variables related to infection among groups of patients submitted to surgical repair of coarctation of the aorta.
| Variable | |
|---|---|
|
| |
| Group A × Group B | 0.731 |
| Group A × Group C | 0.073 |
| Group B × Group C | 0.144 |
|
| |
| Group A × Group B | 0.364 |
| Group A × Group C | 0.704 |
| Group B × Group C | 0.7368 |
|
| |
| Group A × Group B | 0.112 |
| Group A × Group C | 0.854 |
| Group B × Group C | 0.313 |
Group A=34 patients; group B=24 patients; group C=14 patients
| Abbreviations, acronyms & symbols | |
|---|---|
| CoAo | = Coarctation of the aorta |
| CPB | = Cardiopulmonary bypass |
| FAMERP | = Faculdade de Medicina de São José do Rio Preto |
| FUNFARME | = Fundação Faculdade Regional de Medicina de São José do Rio Preto |
| ICU | = Intensive care unit |
| IQIC | = International Quality Improvement Collaborative |
| MV | = Mechanical ventilation |
| PDA | = Persistence of ductus arteriosus |
| PTFE | = Polytetrafluoroethylene |
| SD | = Standard deviation |
| VAP | = Ventilator-associated pneumonia |
| Authors' roles & responsibilities | |||
|---|---|---|---|
| ANM | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published | ACM | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| UAC | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published | CHM | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| FCMC | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published | MRRC | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| GA | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published | FCGBS | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| RBP | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published | BCB | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |